Clear Harbor Asset Management, LLC Puma Biotechnology, Inc. Transaction History

Clear Harbor Asset Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 11, 2019	SELL	$20.07 - $46.7 $218,582 - $508,609	-10,891 Closed	0 $0
Q3 2018 Oct 26, 2018	BUY	$41.2 - $59.85 $160,062 - $232,517	3,885 Added 55.45%	10,891 $441,000
Q2 2018 Aug 03, 2018	BUY	$48.3 - $68.25 $176,101 - $248,839	3,646 Added 108.51%	7,006 $414,000
Q1 2018 May 01, 2018	BUY	$59.7 - $99.25 $26,865 - $44,662	450 Added 15.46%	3,360 $229,000
Q4 2017 Jan 23, 2018	BUY	$93.85 - $132.45 $273,103 - $385,429	2,910	2,910 $288,000

101

29M

50.6K

16.3K

Ticker PBYI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,556,000
Market Cap $139M
Description
Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company's drug candidates include PB272 neratinib (oral) for the patients with early stage HER2-overexpressed/amplified breast cancer; PB272 (neratinib, oral) for...

Get notified when there are updates to the investment portfolio of Clear Harbor Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Clear Harbor Asset Management, LLC with notifications on news.